444 related articles for article (PubMed ID: 12297049)
1. Crystal structure of a truncated epidermal growth factor receptor extracellular domain bound to transforming growth factor alpha.
Garrett TP; McKern NM; Lou M; Elleman TC; Adams TE; Lovrecz GO; Zhu HJ; Walker F; Frenkel MJ; Hoyne PA; Jorissen RN; Nice EC; Burgess AW; Ward CW
Cell; 2002 Sep; 110(6):763-73. PubMed ID: 12297049
[TBL] [Abstract][Full Text] [Related]
2. Identification of a determinant of epidermal growth factor receptor ligand-binding specificity using a truncated, high-affinity form of the ectodomain.
Elleman TC; Domagala T; McKern NM; Nerrie M; Lönnqvist B; Adams TE; Lewis J; Lovrecz GO; Hoyne PA; Richards KM; Howlett GJ; Rothacker J; Jorissen RN; Lou M; Garrett TP; Burgess AW; Nice EC; Ward CW
Biochemistry; 2001 Jul; 40(30):8930-9. PubMed ID: 11467954
[TBL] [Abstract][Full Text] [Related]
3. Crystal structure of the complex of human epidermal growth factor and receptor extracellular domains.
Ogiso H; Ishitani R; Nureki O; Fukai S; Yamanaka M; Kim JH; Saito K; Sakamoto A; Inoue M; Shirouzu M; Yokoyama S
Cell; 2002 Sep; 110(6):775-87. PubMed ID: 12297050
[TBL] [Abstract][Full Text] [Related]
4. NMR study of the differential contributions of residues of transforming growth factor alpha to association with its receptor.
McInnes C; Grothe S; O'Connor-McCourt M; Sykes BD
Protein Eng; 2000 Mar; 13(3):143-7. PubMed ID: 10775655
[TBL] [Abstract][Full Text] [Related]
5. The linear C-terminal regions of epidermal growth factor (EGF) and transforming growth factor-alpha bind to different epitopes on the human EGF receptor.
Lenferink AE; De Roos AD; Van Vugt MJ; Van de Poll ML; Van Zoelen EJ
Biochem J; 1998 Nov; 336 ( Pt 1)(Pt 1):147-51. PubMed ID: 9806896
[TBL] [Abstract][Full Text] [Related]
6. The significance of valine 33 as a ligand-specific epitope of transforming growth factor alpha.
Puddicombe SM; Chamberlin SG; MacGarvie J; Richter A; Drummond DR; Collins J; Wood L; Davies DE
J Biol Chem; 1996 Jun; 271(26):15367-72. PubMed ID: 8663070
[TBL] [Abstract][Full Text] [Related]
7. Molecular determinants of epidermal growth factor binding: a molecular dynamics study.
Sanders JM; Wampole ME; Thakur ML; Wickstrom E
PLoS One; 2013; 8(1):e54136. PubMed ID: 23382875
[TBL] [Abstract][Full Text] [Related]
8. The extracellular domain of the epidermal growth factor receptor. Studies on the affinity and stoichiometry of binding, receptor dimerization and a binding-domain mutant.
Brown PM; Debanne MT; Grothe S; Bergsma D; Caron M; Kay C; O'Connor-McCourt MD
Eur J Biochem; 1994 Oct; 225(1):223-33. PubMed ID: 7925442
[TBL] [Abstract][Full Text] [Related]
9. Structural evidence for loose linkage between ligand binding and kinase activation in the epidermal growth factor receptor.
Lu C; Mi LZ; Grey MJ; Zhu J; Graef E; Yokoyama S; Springer TA
Mol Cell Biol; 2010 Nov; 30(22):5432-43. PubMed ID: 20837704
[TBL] [Abstract][Full Text] [Related]
10. Binding specificities and affinities of egf domains for ErbB receptors.
Jones JT; Akita RW; Sliwkowski MX
FEBS Lett; 1999 Mar; 447(2-3):227-31. PubMed ID: 10214951
[TBL] [Abstract][Full Text] [Related]
11. Polymorphism of the epidermal growth factor receptor extracellular ligand binding domain: the dimer interface depends on domain stabilization.
Zhang Z; Wriggers W
Biochemistry; 2011 Mar; 50(12):2144-56. PubMed ID: 21275429
[TBL] [Abstract][Full Text] [Related]
12. Mechanisms for kinase-mediated dimerization of the epidermal growth factor receptor.
Lu C; Mi LZ; Schürpf T; Walz T; Springer TA
J Biol Chem; 2012 Nov; 287(45):38244-53. PubMed ID: 22988250
[TBL] [Abstract][Full Text] [Related]
13. Structure-based minimization of transforming growth factor-alpha (TGF-alpha) through NMR analysis of the receptor-bound ligand. Design, solution structure, and activity of TGF-alpha 8-50.
McInnes C; Wang J; Al Moustafa AE; Yansouni C; O'Connor-McCourt M; Sykes BD
J Biol Chem; 1998 Oct; 273(42):27357-63. PubMed ID: 9765263
[TBL] [Abstract][Full Text] [Related]
14. Structural analysis of the catalytically inactive kinase domain of the human EGF receptor 3.
Jura N; Shan Y; Cao X; Shaw DE; Kuriyan J
Proc Natl Acad Sci U S A; 2009 Dec; 106(51):21608-13. PubMed ID: 20007378
[TBL] [Abstract][Full Text] [Related]
15. TACE/ADAM17 processing of EGFR ligands indicates a role as a physiological convertase.
Lee DC; Sunnarborg SW; Hinkle CL; Myers TJ; Stevenson MY; Russell WE; Castner BJ; Gerhart MJ; Paxton RJ; Black RA; Chang A; Jackson LF
Ann N Y Acad Sci; 2003 May; 995():22-38. PubMed ID: 12814936
[TBL] [Abstract][Full Text] [Related]
16. A single ligand is sufficient to activate EGFR dimers.
Liu P; Cleveland TE; Bouyain S; Byrne PO; Longo PA; Leahy DJ
Proc Natl Acad Sci U S A; 2012 Jul; 109(27):10861-6. PubMed ID: 22699492
[TBL] [Abstract][Full Text] [Related]
17. The ErbB/HER family of protein-tyrosine kinases and cancer.
Roskoski R
Pharmacol Res; 2014 Jan; 79():34-74. PubMed ID: 24269963
[TBL] [Abstract][Full Text] [Related]
18. The extracellular region of ErbB4 adopts a tethered conformation in the absence of ligand.
Bouyain S; Longo PA; Li S; Ferguson KM; Leahy DJ
Proc Natl Acad Sci U S A; 2005 Oct; 102(42):15024-9. PubMed ID: 16203964
[TBL] [Abstract][Full Text] [Related]
19. EGF activates its receptor by removing interactions that autoinhibit ectodomain dimerization.
Ferguson KM; Berger MB; Mendrola JM; Cho HS; Leahy DJ; Lemmon MA
Mol Cell; 2003 Feb; 11(2):507-17. PubMed ID: 12620237
[TBL] [Abstract][Full Text] [Related]
20. Structural analysis of an epidermal growth factor/transforming growth factor-alpha chimera with unique ErbB binding specificity.
Wingens M; Walma T; van Ingen H; Stortelers C; van Leeuwen JE; van Zoelen EJ; Vuister GW
J Biol Chem; 2003 Oct; 278(40):39114-23. PubMed ID: 12869572
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
